AU Patent

AU2005294318A1 — Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure

Assigned to Novartis AG · Expires 2006-04-20 · 20y expired

What this patent protects

A pharmaceutical composition comprising a renin inhibitor for the prevention of, delay progression to overt to, or the treatment of diastolic dysfunction or diastolic heart failure.

USPTO Abstract

A pharmaceutical composition comprising a renin inhibitor for the prevention of, delay progression to overt to, or the treatment of diastolic dysfunction or diastolic heart failure.

Drugs covered by this patent

Patent Metadata

Patent number: AU2005294318A1
Jurisdiction: AU
Classification: —
Expires: 2006-04-20
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.